CW February 2010
Volume 19Issue Number 2 February 2010 ISSN 1059380 Novel, Favorable Prognostic Marker in Cytogenetically Normal AML Helps Predict SurvivalHigh expression of lymphoid enhancer-binding factor 1 (LEF1) is a novel, favorable prognostic marker in cytogenetically normal (CN) acute myeloid leukemia (AML), and is associated with upregulation of T-lymphoid lineage markers in AML blasts.
Sources and Additional Reading: Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2010Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
